Evolution of pharma sales in the COVID-19 pandemic caused significant market interruptions that forever modified the drug business and required novel ways to deal with Healthcare Professionals (HCP) and patient commitment. During a new board with Dan McCormick, President of Generis Solutions, a specific administration counseling firm serving the existing science industry, we examined COVID-19’s […]
